Curaxis Pharmaceutical (Curaxis Pharmaceutical) Price-to-Tangible-Book : (As of May. 05, 2024)

View and export this data going back to . Start your Free Trial

What is Curaxis Pharmaceutical Price-to-Tangible-Book?

As of today (2024-05-05), Curaxis Pharmaceutical's share price is $0.0006. Curaxis Pharmaceutical's Tangible Book per Share of Dec. 2011 for the quarter that ended in Dec. 2011 was $-0.10. Hence, Curaxis Pharmaceutical's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Curaxis Pharmaceutical's Price-to-Tangible-Book or its related term are showing as below:

CURXQ's Price-to-Tangible-Book is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 2.35
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Curaxis Pharmaceutical's share price is $0.0006. Curaxis Pharmaceutical's Book Value per Sharefor the quarter that ended in Dec. 2011 was $-0.10. Hence, Curaxis Pharmaceutical's P/B Ratio of today is .

Curaxis Pharmaceutical Price-to-Tangible-Book Historical Data

The historical data trend for Curaxis Pharmaceutical's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curaxis Pharmaceutical Price-to-Tangible-Book Chart

Curaxis Pharmaceutical Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Price-to-Tangible-Book

Curaxis Pharmaceutical Semi-Annual Data
	Dec08	Dec09	Dec10	Dec11
Price-to-Tangible-Book	-	-	-	-

Competitive Comparison of Curaxis Pharmaceutical's Price-to-Tangible-Book

For the Drug Manufacturers - General subindustry, Curaxis Pharmaceutical's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curaxis Pharmaceutical's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curaxis Pharmaceutical's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Curaxis Pharmaceutical's Price-to-Tangible-Book falls into.

Curaxis Pharmaceutical Price-to-Tangible-Book Calculation

Curaxis Pharmaceutical's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2011 )
	=	0.0006	/	-0.103
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Curaxis Pharmaceutical Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Curaxis Pharmaceutical's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Curaxis Pharmaceutical (Curaxis Pharmaceutical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curaxis Pharmaceutical Corp (OTCPK:CURXQ) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.curaxispharma.com

Curaxis Pharmaceutical Corp was incorporated in Delaware on February 27, 2001. It is a specialty pharmaceutical company with a hormone drug product candidate for the treatment of Alzheimer's disease. The Company's therapeutic platform is based on the hypothesis that diseases of aging may be caused by age-related changes in the function of the hypothalamic-pituitary-gonadal (HPG) axis. The HPG axis is a hormonal endocrine feedback loop that controls development, reproduction and aging in animals. This drug development platform is built on the premise that hormones associated with this feedback loop are beneficial early in life, when they promote growth and development, but are harmful later in life when the mechanism for feedback is compromised, thereby leading to disease processes, including pathologies associated with Alzheimer's disease and various cancers. Its discovery of similar hormonal signaling mechanisms at the cellular level in brain tissue from Alzheimer's patients and in multiple tumors will enable it to develop significant new treatments for Alzheimer's disease and may have applications for many cancers.

Executives

Timothy R Wright	director, officer: Chief Executive Officer	C/O CURAXIS, 1004 CHAGFORD WAY, RALEIGH NC 27614
Michael W George	director	C/O CURAXIS, 1004 CHAGFORD WAY, RALEIGH NC 27614

Curaxis Pharmaceutical (Curaxis Pharmaceutical) Headlines

No Headlines